Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Alloway

Showing results (81-90 of 164) with videos related to

Pageof 17
Sort By:
Transplantation|July 28, 2012
Prospective evaluation of the toxicity profile of proteasome inhibitor-based therapy in renal transplant candidates and recipientsNicole Schmidt, Rita R Alloway, R Carlin Walsh, et al.
Transplantation Proceedings|September 13, 2015
Case Report: Successful Living Donor Kidney Transplantation in a Highly Human Leukocyte Antigen-Sensitized Recipient With a Positive Cytotoxic Crossmatch Using Bortezomib-Based Desensitization Without Intravenous ImmunoglobulinJ Y Revollo, M C Cuffy, B G Abu Jawdeh, et al.
Journal of Clinical Pharmacology|June 24, 2003
The effect of CYP3A5 and MDR1 polymorphic expression on cyclosporine oral disposition in renal transplant patientsCharles R Yates, Wenhui Zhang, Pengfei Song, et al.
Transplantation|February 1, 2000
Simultaneous kidney-pancreas transplantation without antilymphocyte inductionK S Reddy, R J Stratta, H Shokouh-Amiri, et al.
Transplantation Proceedings|April 26, 2005
Chemotherapy for posttransplant lymphoproliferative disorder: the Israel Penn International Transplant Tumor Registry experienceJ F Buell, T G Gross, M J Hanaway, et al.
Frontiers in Medicine|June 13, 2017
Contrast-Induced Nephropathy in Renal Transplant Recipients: A Single Center ExperienceBassam G Abu Jawdeh, Anthony C Leonard, Yuvraj Sharma, et al.
Transplantation|October 14, 2004
Recurrence risk after organ transplantation in patients with a history of Hodgkin disease or non-Hodgkin lymphomaJennifer Trofe, Joseph F Buell, E Steve Woodle, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 25, 2019
A prospective, iterative, adaptive trial of carfilzomib-based desensitizationSimon Tremblay, James J Driscoll, Adele Rike-Shields, et al.
Clinical Transplantation|March 15, 2008
Cardiovascular risk, cardiovascular events, and metabolic syndrome in renal transplantation: comparison of early steroid withdrawal and chronic steroidsAdele H Rike, Gautham Mogilishetty, Rita R Alloway, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|October 22, 2004
Posttransplant malignancyJennifer Trofe, Thomas M Beebe, Joseph F Buell, et al.
Pageof 17

Showing results (81-90 of 164) with videos related to

Sort By:
Pageof 17
Transplantation|July 28, 2012
Prospective evaluation of the toxicity profile of proteasome inhibitor-based therapy in renal transplant candidates and recipientsNicole Schmidt, Rita R Alloway, R Carlin Walsh, et al.
Transplantation Proceedings|September 13, 2015
Case Report: Successful Living Donor Kidney Transplantation in a Highly Human Leukocyte Antigen-Sensitized Recipient With a Positive Cytotoxic Crossmatch Using Bortezomib-Based Desensitization Without Intravenous ImmunoglobulinJ Y Revollo, M C Cuffy, B G Abu Jawdeh, et al.
Journal of Clinical Pharmacology|June 24, 2003
The effect of CYP3A5 and MDR1 polymorphic expression on cyclosporine oral disposition in renal transplant patientsCharles R Yates, Wenhui Zhang, Pengfei Song, et al.
Transplantation|February 1, 2000
Simultaneous kidney-pancreas transplantation without antilymphocyte inductionK S Reddy, R J Stratta, H Shokouh-Amiri, et al.
Transplantation Proceedings|April 26, 2005
Chemotherapy for posttransplant lymphoproliferative disorder: the Israel Penn International Transplant Tumor Registry experienceJ F Buell, T G Gross, M J Hanaway, et al.
Frontiers in Medicine|June 13, 2017
Contrast-Induced Nephropathy in Renal Transplant Recipients: A Single Center ExperienceBassam G Abu Jawdeh, Anthony C Leonard, Yuvraj Sharma, et al.
Transplantation|October 14, 2004
Recurrence risk after organ transplantation in patients with a history of Hodgkin disease or non-Hodgkin lymphomaJennifer Trofe, Joseph F Buell, E Steve Woodle, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 25, 2019
A prospective, iterative, adaptive trial of carfilzomib-based desensitizationSimon Tremblay, James J Driscoll, Adele Rike-Shields, et al.
Clinical Transplantation|March 15, 2008
Cardiovascular risk, cardiovascular events, and metabolic syndrome in renal transplantation: comparison of early steroid withdrawal and chronic steroidsAdele H Rike, Gautham Mogilishetty, Rita R Alloway, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|October 22, 2004
Posttransplant malignancyJennifer Trofe, Thomas M Beebe, Joseph F Buell, et al.
Pageof 17